Revenue: The sum of all revenue fields included for a company's operating activities.
Relay Therapeutics, Inc. (RLAY) had Revenue of $10.01M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$10.01M |
$-337.71M |
|
-- |
|
$10.01M |
|
$382.48M |
|
$-372.47M |
|
$34.76M |
|
$-337.71M |
|
$-337.71M |
|
$-337.71M |
|
$-337.71M |
|
$-337.71M |
|
$-337.71M |
|
$-372.47M |
|
$-379.32M |
|
142.87M |
|
142.87M |
|
$-2.36 |
|
$-2.36 |
|
| Balance Sheet Financials | |
$809.20M |
|
$5.91M |
|
$62.09M |
|
$871.30M |
|
$50.73M |
|
-- |
|
$42.77M |
|
$93.50M |
|
$777.79M |
|
$775.49M |
|
$777.79M |
|
167.76M |
|
| Cash Flow Statement Financials | |
$-249.11M |
|
$-41.08M |
|
$270.15M |
|
$146.44M |
|
$126.41M |
|
$-20.04M |
|
$94.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.95 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-3722.07% |
|
-3722.07% |
|
-3790.54% |
|
-3374.72% |
|
-3374.72% |
|
$-251.12M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-43.42% |
|
-43.55% |
|
-38.76% |
|
-43.42% |
|
$4.64 |
|
$-1.76 |
|
$-1.74 |
|